Activation of Akt/GSK3β and Akt/Bcl-2 signaling pathways in nickel-transformed BEAS-2B cells

International Journal of Oncology

Volumn 39, Issue 5, 2011, Pages 1285-1294

  Pan, Jing Ju ^a,b   Chang, Qing Shan ^b   Wang, Xin ^b   Son, Young Ok ^b   Liu, Jiankang ^b   Zhang, Zhuo ^b   Bi, Yong Yi ^c   Shi, Xianglin ^b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b UNIVERSITY OF KENTUCKY   (United States)

^c WUHAN UNIVERSITY   (China)

Author keywords

Cell transformation; Nickel; Signal pathway

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICKEL CHLORIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; REACTIVE NITROGEN SPECIES; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; ARTICLE; BRONCHUS; CARCINOGENESIS; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

CARCINOGENS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; ENZYME ACTIVATION; EPITHELIAL CELLS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NICKEL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 80053198451     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1157     Document Type: Article

References (47)

1. Bellacosa A, Testa JR, Staal SP and Tsichlis PN: A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254: 274-277, 1991. (Pubitemid 21917339)
2. Franke TF: PI3K/Akt: getting it right matters. Oncogene 27: 6473-6488, 2008.
3. Bellacosa A, Kumar CC, Di Cristofano A and Testa JR: Activation of AKT kinases in cancer: implications for therapeutic targeting. Adv Cancer Res 94: 29-86, 2005. (Pubitemid 41202364)
4. Altomare DA and Testa JR: Perturbations of the AKT signaling pathway in human cancer. Oncogene 24: 7455-7464, 2005. (Pubitemid 41637985)
5. Hennessy BT, Smith DL, Ram PT, Lu Y and Mills GB: Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 4: 988-1004, 2005.
6. Morley S, Wagner J, Kauppinen K, Sherman M and Manor D: Requirement for Akt-mediated survival in cell transformation by the dbl oncogene. Cell Signal 19: 211-218, 2007. (Pubitemid 44880257)
7. Bedogni B, Welford SM, Cassarino DS, Nickoloff BJ, Giaccia AJ and Powell MB: The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation. Cancer Cell 8: 443-454, 2005. (Pubitemid 41773448)
8. Sun M, Wang G, Paciga JE, et al: AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol 159: 431-437, 2001. (Pubitemid 32751073)
9. Oller AR, Costa M and Oberdorster G: Carcinogenicity assessment of selected nickel compounds. Toxicol Appl Pharmacol 143: 152-166, 1997. (Pubitemid 27130618)
10. International Agency for Research on Cancer (IARC): Nickel and nickel compounds. Summ Eval 49: 257, 1990.
11. Ke Q, Davidson T, Chen H, Kluz T and Costa M: Alterations of histone modifications and transgene silencing by nickel chloride. Carcinogenesis 27: 1481-1488, 2006. (Pubitemid 43985421)
12. Costa M, Davidson TL, Chen H, et al: Nickel carcinogenesis: epigenetics and hypoxia signaling. Mutat Res 592: 79-88, 2005. (Pubitemid 41714046)
13. Ellen TP, Kluz T, Harder ME, Xiong J and Costa M: Heterochromatinization as a potential mechanism of nickel-induced carcinogenesis. Biochemistry 48: 4626-4632, 2009.
14. Salnikow K and Zhitkovich A: Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 21: 28-44, 2008. (Pubitemid 351219706)
15. Reddel RR, Ke Y, Gerwin BI, et al: Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 48: 1904-1909, 1988.
16. Gao N, Rahmani M, Dent P and Grant S: 2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process. Oncogene 24: 3797-3809, 2005. (Pubitemid 40826878)
17. Lin X and Costa M: Transformation of human osteoblasts to anchorage-independent growth by insoluble nickel particles. Environ Health Perspect 102 (Suppl 3): S289-S292, 1994.
18. Miura T, Patierno SR, Sakuramoto T and Landolph JR: Morphological and neoplastic transformation of C3H/10T1/2 Cl 8 mouse embryo cells by insoluble carcinogenic nickel compounds. Environ Mol Mutagen 14: 65-78, 1989. (Pubitemid 19245678)
19. Downward J: Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10: 262-267, 1998.
20. Kau TR, Schroeder F, Ramaswamy S, et al: A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. Cancer Cell 4: 463-476, 2003. (Pubitemid 38050043)
21. Manning BD and Cantley LC: AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274, 2007. (Pubitemid 46962095)
22. Stambolic V, Suzuki A, De la Pompa JL, et al: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39, 1998. (Pubitemid 28458022)
23. Nave BT, Ouwens M, Withers DJ, Alessi DR and Shepherd PR: Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J 344 Pt 2: 427-431, 1999. (Pubitemid 30011599)
24. Vogt PK: PI 3-kinase, mTOR, protein synthesis and cancer. Trends Mol Med 7: 482-484, 2001.
25. Grimes CA and Jope RS: The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65: 391-426, 2001. (Pubitemid 32781670)
26. Datta SR, Dudek H, Tao X, et al: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241, 1997. (Pubitemid 27456390)
27. Yip KW and Reed JC: Bcl-2 family proteins and cancer. Oncogene 27: 6398-6406, 2008.
28. Szatrowski TP and Nathan CF: Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res 51: 794-798, 1991.
29. Clerkin JS, Naughton R, Quiney C and Cotter TG: Mechanisms of ROS modulated cell survival during carcinogenesis. Cancer Lett 266: 30-36, 2008.
30. Bishop JM: The molecular genetics of cancer. Science 235: 305-311, 1987.
31. Zhang Q, Salnikow K, Kluz T, Chen LC, Su WC and Costa M: Inhibition and reversal of nickel-induced transformation by the histone deacetylase inhibitor trichostatin A. Toxicol Appl Pharmacol 192: 201-211, 2003. (Pubitemid 37311337)
32. Ji WD, Chen JK, Lu JC, Wu ZL, Yi F and Feng SM: Alterations of FHIT gene and P16 gene in nickel transformed human bronchial epithelial cells. Biomed Environ Sci 19: 277-284, 2006. (Pubitemid 44505565)
33. Ji W, Yang L, Yu L, et al: Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells. Carcinogenesis 29: 1267-1275, 2008. (Pubitemid 351958708)
34. Verma R, Ramnath J, Clemens F, Kaspin LC and Landolph JR: Molecular biology of nickel carcinogenesis: identification of differentially expressed genes in morphologically transformed C3H10T1/2 Cl 8 mouse embryo fibroblast cell lines induced by specific insoluble nickel compounds. Mol Cell Biochem 255: 203-216, 2004. (Pubitemid 38159780)
35. Landolph JR, Verma A, Ramnath J and Clemens F: Molecular biology of deregulated gene expression in transformed C3H/10T1/2 mouse embryo cell lines induced by specific insoluble carcinogenic nickel compounds. Environ Health Perspect 110 (Suppl 5): 845-850, 2002. (Pubitemid 35276879)
36. Chen CH, Lu PJ, Chen YC, et al: FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway. Oncogene 26: 4272-4283, 2007. (Pubitemid 46975797)
37. Nomura M, He Z, Koyama I, Ma WY, Miyamoto K and Dong Z: Involvement of the Akt/mTOR pathway on EGF-induced cell transformation. Mol Carcinog 38: 25-32, 2003. (Pubitemid 37122317)
38. Cross DA, Alessi DR, Cohen P, Andjelkovich M and Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789, 1995. (Pubitemid 26004411)
39. Harwood AJ: Regulation of GSK-3: a cellular multiprocessor. Cell 105: 821-824, 2001.
40. Polakis P: Wnt signaling and cancer. Genes Dev 14: 1837-1851, 2000.
41. Flacke JP, Kumar S, Kostin S, Reusch HP and Ladilov Y: Acidic preconditioning protects endothelial cells against apoptosis through p38- and Akt-dependent Bcl-xL overexpression. Apoptosis 14: 90-96, 2009.
42. Pugazhenthi S, Nesterova A, Sable C, et al: Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275: 10761-10766, 2000. (Pubitemid 30212704)
43. Qian J, Zou Y, Rahman JS, Lu B and Massion PP: Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung. Mol Cancer Ther 8: 101-109, 2009.
44. Bouchard C, Marquardt J, Bras A, Medema RH and Eilers M: Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins. EMBO J 23: 2830-2840, 2004. (Pubitemid 39013555)
45. Classon M and Harlow E: The retinoblastoma tumour suppressor in development and cancer. Nat Rev Cancer 2: 910-917, 2002. (Pubitemid 37328892)
46. Iuliano R, Trapasso F, Stella A, et al: Pivotal role of the RB family proteins in in vitro thyroid cell transformation. Exp Cell Res 260: 257-267, 2000.
47. Lin X, Dowjat WK and Costa M: Nickel-induced transformation of human cells causes loss of the phosphorylation of the retinoblastoma protein. Cancer Res 54: 2751-2754, 1994. (Pubitemid 24173769)